Flurbiprofen ameliorated obesity by attenuating leptin resistance induced by endoplasmic reticulum stress.
Flurbiprofen ameliorated obesity by attenuating leptin resistance induced by endoplasmic reticulum stress.
复制标题
弗拉伯利酮通过衰减内质网应激诱导的瘦素耐药性来改善肥胖症。
DOI:
10.1002/emmm.201303227
复制
发表时间:
2014-03
影响因子:
11.1
通讯作者:
Ozawa, Koichiro
中科院分区:
文献类型:
--
作者:
Hosoi, Toru;Yamaguchi, Rie;Noji, Kikuko;Matsuo, Suguru;Baba, Sachiko;Toyoda, Keisuke;Suezawa, Takahiro;Kayano, Takaaki;Tanaka, Shinpei;Ozawa, Koichiro
Endoplasmic reticulum (ER) stress, caused by the accumulation of unfolded proteins, is involved in the development of obesity. We demonstrated that flurbiprofen, a nonsteroidal anti-inflammatory drug (NSAID), exhibited chaperone activity, which reduced protein aggregation and alleviated ER stress-induced leptin resistance, characterized by insensitivity to the actions of the anti-obesity hormone leptin. This result was further supported by flurbiprofen attenuating high-fat diet-induced obesity in mice. The other NSAIDs tested did not exhibit such effects, which suggested that this anti-obesity action is mediated independent of NSAIDs. Using ferriteglycidyl methacrylate beads, we identified aldehyde dehydrogenase as the target of flurbiprofen, but not of the other NSAIDs. These results suggest that flurbiprofen may have unique pharmacological properties that reduce the accumulation of unfolded proteins and may represent a new class of drug for the fundamental treatment of obesity. Subject Categories Metabolism; Pharmacology & Drug Discovery
登录
查看更多内容
影响因子:
3.7
作者:
Baker SS;Baker RD;Liu W;Nowak NJ;Zhu L
通讯作者:
Zhu L
影响因子:
4.7
作者:
Ohsawa, I;Nishimaki, K;Ohta, S
通讯作者:
Ohta, S
影响因子:
16
作者:
Harding, HP;Novoa, I;Ron, D
通讯作者:
Ron, D
影响因子:
4.8
作者:
Miwa, I;Ichimura, N;Taniguchi, S
通讯作者:
Taniguchi, S
影响因子:
11.8
作者:
Cheng, A;Uetani, N;Tremblay, ML
通讯作者:
Tremblay, ML